FdaApplication

ANDA 207690

Back to search

Identifiers

Properties

PropertyValue
applicant_nameAMNEAL PHARMACEUTICALS LLC
application_typeANDA
approval_date2021-03-11

Products (2)

ProductActive ingredientStrengthDosage form
RANOLAZINERANOLAZINE500MGTABLET, EXTENDED RELEASE;ORAL
RANOLAZINERANOLAZINE1GMTABLET, EXTENDED RELEASE;ORAL

2 products